article
Fast-tracking the approach to drug discovery and development
Mundipharma EDO GmbH's Dr Thomas Mehrling talks through the benefits of streamlining the drug discovery and development process using the EDO model...
List view / Grid view
Drug Discovery Processes
news
Biologic treatments for inflammatory bowel disease help heal the intestine
Although anti-inflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis, the mucosal lining of the intestine often remains ulcerated, and many patients still ultimately require surgery.
whitepaper
Brochure: Custom Assay Development
The Custom Assay Development (CAD) program at DiscoverX develops tailor-made cell lines optimised for your needs, enabling you to jump start your drug discovery programs...
news
Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery Program
Charles River Laboratories today announced that it has extended its longstanding, strategic, integrated drug discovery partnership with Chiesi Farmaceutici SpA in the field of respiratory disease...
webinar
Acute and inflammatory in vivo pain models
10 March 2017 | By Charles River
This webinar discusses our newly validated acute and inflammatory in vivo pain models, including information on how they were validated and how they can be used to test new pain treatment compounds, eventually leading to clinical translation...
news
IT system failures in sample management
Successful compound management and biological sample management stand as key enablers within the drug discovery process...
product
ProteinSimple Milo
12 January 2017 | By ProteinSimple
Single-Cell Western system capable of analysing protein expression in ~1,000 single-cells in parallel to unlock heterogeneity...
news
Chronos and Aptuit partner up for addictive behaviour programmes
The companies will work together on integrated drug discovery - medicinal and computational chemistry, biology and DMPK - to optimise Chronos’ selective orexin 1 antagonists that have shown promise in treating addiction.
webinar
New strategy to identify small molecule therapies
1 December 2016 | By Charles River
This webinar details a successful new strategy to identify small molecule therapies to treat protein-destabilizing monogenic disorders...
whitepaper
Whitepaper: KINOMEscan® ELECT Kinase screening and profiling services
Support your kinase inhibitor drug discovery programs with the most comprehensive kinase assay menu from DiscoverX’s KINOMEscan screening and profiling services, now with the fastest available turnaround time of 5 days for the ELECT services*...
whitepaper
Poster note: Target discovery program in systemic sclerosis
Novel candidate drug targets for systemic scleroderma were identified using RNAi in phenotypic assays in scleroderma patient-derived fibroblasts...
product
Bio-Rad Bio-Plex Multiplex Immunoassay System
4 August 2016 | By Bio-Rad Laboratories
The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples...
product
Bio-Rad S3e™ Cell Sorter
4 August 2016 | By Bio-Rad Laboratories
The Bio-Rad automated S3e™ Cell Sorter allows you to perform simple 1–4 colour sorts in less than 30 minutes and greatly enhances your experimental success...
product
IntelliCyt MultiCyt Reagent kits
28 July 2016 | By IntelliCyt Corporation
Robust mix and read kits for cell- and bead-based screening applications...
product
EMD Millipore: Verifi(Ab)le – Neuroscience Antibodies
28 June 2016 | By Merck KGaA
EMD Millipore is continually developing and refining tools and technologies for the study of neuroscience. Researchers can count on our comprehensive portfolio of dependable, high-quality solutions for elucidating questions related to neuroscience...
